Ashfield Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $12.6M | Sell |
55,789
-234
| -0.4% | -$56.7K | 1.06% | 26 |
|
|
2022
Q2 | $13.6M | Sell |
56,023
-94
| -0.2% | -$23K | 1.06% | 27 |
|
|
2022
Q1 | $13.6M | Sell |
56,117
-731
| -1% | -$168K | 0.88% | 30 |
|
|
2021
Q4 | $12.8M | Sell |
56,848
-442
| -0.8% | -$93.3K | 0.82% | 31 |
|
|
2021
Q3 | $12.2M | Sell |
57,290
-378
| -0.7% | -$87K | 0.87% | 29 |
|
|
2021
Q2 | $14.1M | Sell |
57,668
-934
| -2% | -$230K | 1% | 26 |
|
|
2021
Q1 | $14.6M | Sell |
58,602
-1,468
| -2% | -$350K | 1.16% | 24 |
|
|
2020
Q4 | $13.8M | Buy |
60,070
+373
| +0.6% | +$86K | 1.12% | 23 |
|
|
2020
Q3 | $15.2M | Sell |
59,697
-681
| -1% | -$169K | 1.38% | 21 |
|
|
2020
Q2 | $14.2M | Sell |
60,378
-424
| -0.7% | -$96.7K | 1.41% | 20 |
|
|
2020
Q1 | $12.3M | Buy |
60,802
+601
| +1% | +$131K | 1.5% | 20 |
|
|
2019
Q4 | $14.5M | Buy |
60,201
+860
| +1% | +$190K | 1.44% | 20 |
|
|
2019
Q3 | $11.5M | Buy |
59,341
+514
| +0.9% | +$98.7K | 1.24% | 26 |
|
|
2019
Q2 | $10.8M | Sell |
58,827
-1,260
| -2% | -$226K | 1.16% | 29 |
|
|
2019
Q1 | $11.4M | Buy |
60,087
+642
| +1% | +$123K | 1.25% | 25 |
|
|
2018
Q4 | $11.6M | Buy |
59,445
+2,663
| +5% | +$520K | 1.51% | 15 |
|
|
2018
Q3 | $11.8M | Sell |
56,782
-1,105
| -2% | -$218K | 1.32% | 20 |
|
|
2018
Q2 | $10.7M | Sell |
57,887
-770
| -1% | -$136K | 1.33% | 16 |
|
|
2018
Q1 | $10M | Sell |
58,657
-857
| -1% | -$157K | 1.3% | 18 |
|
|
2017
Q4 | $10.3M | Sell |
59,514
-1,635
| -3% | -$289K | 1.33% | 17 |
|
|
2017
Q3 | $11.4M | Sell |
61,149
-1,286
| -2% | -$228K | 1.53% | 13 |
|
|
2017
Q2 | $10.8M | Buy |
62,435
+26,299
| +73% | +$4.28M | 1.47% | 13 |
|
|
2017
Q1 | $5.93M | Sell |
36,136
-8,465
| -19% | -$1.41M | 0.82% | 41 |
|
|
2016
Q4 | $6.52M | Sell |
44,601
-3,733
| -8% | -$562K | 0.64% | 55 |
|
|
2016
Q3 | $8.06M | Sell |
48,334
-331
| -0.7% | -$56K | 0.66% | 52 |
|
|
2016
Q2 | $7.4M | Hold |
48,665
| – | – | 0.6% | 56 |
|
|
2016
Q1 | $7.3M | Buy |
48,665
+261
| +0.5% | +$38.8K | 0.53% | 58 |
|
|
2015
Q4 | $7.86M | Sell |
48,404
-3,406
| -7% | -$535K | 0.54% | 58 |
|
|
2015
Q3 | $7.17M | Buy |
51,810
+237
| +0.5% | +$37.4K | 0.46% | 59 |
|
|
2015
Q2 | $7.92M | Sell |
51,573
-61
| -0.1% | -$9.77K | 0.43% | 58 |
|
|
2015
Q1 | $8.25M | Hold |
51,634
| – | – | 0.44% | 57 |
|
|
2014
Q4 | $8.22M | Sell |
51,634
-201
| -0.4% | -$31.3K | 0.4% | 60 |
|
|
2014
Q3 | $7.28M | Sell |
51,835
-1,156
| -2% | -$151K | 0.35% | 65 |
|
|
2014
Q2 | $6.27M | Sell |
52,991
-2,012
| -4% | -$233K | 0.3% | 71 |
|
|
2014
Q1 | $6.78M | Sell |
55,003
-97
| -0.2% | -$11.8K | 0.33% | 70 |
|
|
2013
Q4 | $6.29M | Hold |
55,100
| – | – | 0.3% | 70 |
|
|
2013
Q3 | $6.17M | Sell |
55,100
-94
| -0.2% | -$10.2K | 0.32% | 68 |
|
|
2013
Q2 | $5.45M | Buy |
+55,194
| New | +$5.73M | 0.29% | 72 |
|
Other funds holding AMGN
Ashfield Capital Partners's AMGN Position: Q3 2022 in Review
Ashfield Capital Partners reduced its Amgen (AMGN) stake by 0.42% in Q3 2022, selling an estimated $56.7K and leaving 55,789 shares worth $12.6M. The position accounts for 1.06% of the portfolio, ranked #26.
Ashfield Capital Partners first reported a position in AMGN in Q2 2013 and has held it in 38 quarters since. The position peaked at $15.2M in Q3 2020. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Ashfield Capital Partners held 55,789 shares of Amgen worth $12.6M as of Q3 2022.
- Ashfield Capital Partners sold 234 Amgen shares in Q3 2022, an estimated $56.7K.
- Amgen made up 1.06% of Ashfield Capital Partners's portfolio in Q3 2022, its #26 holding.
- Ashfield Capital Partners first reported a position in Amgen in Q2 2013 and has held it in 38 quarters since.
- Ashfield Capital Partners's Amgen position peaked at $15.2M in Q3 2020.
- 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Ashfield Capital Partners's 13F filing for Q3 2022, filed 10 Nov 2022.